Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike RBD) |
RAS-T093 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection. |
Igg Antibody Laboratories manufactures the s-rbd-specific igg antibody titer reagents distributed by Genprice. The S-Rbd-Specific Igg Antibody Titer reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other S-Rbd-Specific products are available in stock. Specificity: S-Rbd-Specific Category: Igg Group: Antibody Titer
Mouse Anti-SARS-CoV-2 (B.1.1.529) Antibody IgG Titer Serologic Assay Kit (Spike RBD) |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: As of Nov 29th, confirmed cases of a new variant of concern (VOC) B.1.1.529 have been reported in South Africa, Botswana and more than 12 other countries. Thanks to the rapid sequencing efforts of South African scientists, the whole world is now alerted about this potentially devastating lineage, which was assigned the name Omicron by WHO.Omicron is a highly divergent variant with a high number of mutations (26-35) in the spike. Identification of some familiar mutations that also appeared on other VOCs gives rises to concerns of its immune escape potential and higher transmissibility. To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Monkey Anti-SARS-CoV-2 (B.1.1.529) Antibody IgG Titer Serologic Assay Kit (Spike RBD) |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: As of Nov 29th, confirmed cases of a new variant of concern (VOC) B.1.1.529 have been reported in South Africa, Botswana and more than 12 other countries. Thanks to the rapid sequencing efforts of South African scientists, the whole world is now alerted about this potentially devastating lineage, which was assigned the name Omicron by WHO.Omicron is a highly divergent variant with a high number of mutations (26-35) in the spike. Identification of some familiar mutations that also appeared on other VOCs gives rises to concerns of its immune escape potential and higher transmissibility. To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Mouse Anti-SARS-CoV-2 (BA.2) Antibody IgG Titer Serologic Assay Kit (Spike RBD) |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: A more contagious subvariant of omicron, known as BA.2, is spreading across the globe and could soon become the dominant version of Covid-19.It's now the top variant in at least 18 countries and rapidly spreading, representing 35% of all new cases that have been genetically sequenced worldwide, up from 10 countries and 21% of cases the week before, according to new data from the World Health Organization. In the U.S, BA.2 currently makes up 3.8% of genetically sequenced Covid cases, according to the Centers for Disease Control and Prevention.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Mouse Anti-SARS-CoV-2 (B.1.617.2) Antibody IgG Titer Serologic Assay Kit (Spike RBD) |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in the state of Maharashtra in late 2020 and spread throughout India, outcompeting pre-existing lineages including B.1.617.1 (Kappa) and B.1.1.7 (Alpha)1. In vitro, B.1.617.2 is sixfold less sensitive to serum neutralizing antibodies from recovered individuals, and eightfold less sensitive to vaccine-elicited antibodies, compared with wild-type Wuhan-1 bearing D614G. To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Mouse Anti-SARS-CoV-2 (BA.2.12.1) Antibody IgG Titer Serologic Assay Kit (Spike RBD) |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Human Anti-SARS-CoV-2 (BA.5) Antibody IgG Titer Serologic Assay Kit (Spike RBD) |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: According to the data from GISAID, until 25th July, BA.5 was accounted for 52% of the sequence library, making it the dominant strain in a new global outbreak. Some research results showed that BA.5 seems to be the most infectious version of SARS-CoV-2 with the R0 value of 18.6 (about 2.79 in wild type). Furthermore, the strong immune escape ability is also a powerful blessing for BA.5 to quickly become the dominant strain. A report from New York showed that the breakthrough infection capacity of BA.5 should be 4.2 times of BA.1. The latest research shows that BA.5 has also a strong immune escape from the serum of BA.1 infected people, which means that the existing "immune wall" in the population may be ineffective against BA.5.To facilitate the mutant-related research, drug trials and vaccine development in clinical reasearch, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Monkey Anti-SARS-CoV-2 (BA.5) Antibody IgG Titer Serologic Assay Kit (Spike RBD) |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Antibody Titer information
SARS-CoV-2 (2019-nCoV) Spike RBD Antibody Titer Assay Kit |
MBS8124202-5x96Tests |
MyBiosource |
5x96Tests |
EUR 3465 |
SARS-CoV-2 (2019-nCoV) Spike RBD Antibody Titer Assay Kit |
MBS8124202-96Tests |
MyBiosource |
96Tests |
EUR 750 |
Anti-SARS-CoV-2 (B.1.1.529) Antibody IgG1 Titer Serologic Assay Kit (Spike RBD) |
RAS-T065 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: As of Nov 29th, confirmed cases of a new variant of concern (VOC) B.1.1.529 have been reported in South Africa, Botswana and more than 12 other countries. Thanks to the rapid sequencing efforts of South African scientists, the whole world is now alerted about this potentially devastating lineage, which was assigned the name Omicron by WHO.Omicron is a highly divergent variant with a high number of mutations (26-35) in the spike. Identification of some familiar mutations that also appeared on other VOCs gives rises to concerns of its immune escape potential and higher transmissibility. To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure subtype IgG antibodies against the mutants is in urgent need,including IgG1, IgG2 IgG3, IgG4. |
Anti-SARS-CoV-2 (B.1.1.529) Antibody IgG2 Titer Serologic Assay Kit (Spike RBD) |
RAS-T066 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: As of Nov 29th, confirmed cases of a new variant of concern (VOC) B.1.1.529 have been reported in South Africa, Botswana and more than 12 other countries. Thanks to the rapid sequencing efforts of South African scientists, the whole world is now alerted about this potentially devastating lineage, which was assigned the name Omicron by WHO.Omicron is a highly divergent variant with a high number of mutations (26-35) in the spike. Identification of some familiar mutations that also appeared on other VOCs gives rises to concerns of its immune escape potential and higher transmissibility. To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure subtype IgG antibodies against the mutants is in urgent need,including IgG1, IgG2 IgG3, IgG4. |
Anti-SARS-CoV-2 (B.1.1.529) Antibody IgG3 Titer Serologic Assay Kit (Spike RBD) |
RAS-T067 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: As of Nov 29th, confirmed cases of a new variant of concern (VOC) B.1.1.529 have been reported in South Africa, Botswana and more than 12 other countries. Thanks to the rapid sequencing efforts of South African scientists, the whole world is now alerted about this potentially devastating lineage, which was assigned the name Omicron by WHO.Omicron is a highly divergent variant with a high number of mutations (26-35) in the spike. Identification of some familiar mutations that also appeared on other VOCs gives rises to concerns of its immune escape potential and higher transmissibility. To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure subtype IgG antibodies against the mutants is in urgent need,including IgG1, IgG2 IgG3, IgG4. |
Anti-SARS-CoV-2 (B.1.1.529) Antibody IgG4 Titer Serologic Assay Kit (Spike RBD) |
RAS-T068 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: As of Nov 29th, confirmed cases of a new variant of concern (VOC) B.1.1.529 have been reported in South Africa, Botswana and more than 12 other countries. Thanks to the rapid sequencing efforts of South African scientists, the whole world is now alerted about this potentially devastating lineage, which was assigned the name Omicron by WHO.Omicron is a highly divergent variant with a high number of mutations (26-35) in the spike. Identification of some familiar mutations that also appeared on other VOCs gives rises to concerns of its immune escape potential and higher transmissibility. To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure subtype IgG antibodies against the mutants is in urgent need,including IgG1, IgG2 IgG3, IgG4. |
Anti-SARS-CoV-2 (B.1.617.2) Antibody IgG1 Titer Serologic Assay Kit (Spike RBD) |
RAS-T077 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses continual threat to human health due to rapid transmission worldwide. Unprecedented vaccination campaigns have now begun with multiple candidates. To support these studies, ACRO has developed Anti-SARS-CoV-2 subtype antibody Serologic Assay kit including:IgG1, IgG2 IgG3, IgG4. |
Anti-SARS-CoV-2 (B.1.617.2) Antibody IgG3 Titer Serologic Assay Kit (Spike RBD) |
RAS-T078 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses continual threat to human health due to rapid transmission worldwide. Unprecedented vaccination campaigns have now begun with multiple candidates. To support these studies, ACRO has developed Anti-SARS-CoV-2 subtype antibody Serologic Assay kit including:IgG1, IgG2 IgG3, IgG4. |
SARS-CoV-2 (B.1.1.529) Spike RBD Antibody Titer Assay Kit (Mouse) |
MBS8124213-5x96Tests |
MyBiosource |
5x96Tests |
EUR 3465 |
SARS-CoV-2 (B.1.1.529) Spike RBD Antibody Titer Assay Kit (Mouse) |
MBS8124213-96Tests |
MyBiosource |
96Tests |
EUR 750 |
SARS-CoV-2 (B.1.617.2) Spike RBD Antibody Titer Assay Kit (Mouse) |
MBS8124218-5x96Tests |
MyBiosource |
5x96Tests |
EUR 3465 |
SARS-CoV-2 (B.1.617.2) Spike RBD Antibody Titer Assay Kit (Mouse) |
MBS8124218-96Tests |
MyBiosource |
96Tests |
EUR 750 |
SARS-CoV-2 (2019-nCoV) Spike RBD Antibody Titer Assay Kit (Mouse) |
MBS8124206-5x96Tests |
MyBiosource |
5x96Tests |
EUR 3465 |
SARS-CoV-2 (2019-nCoV) Spike RBD Antibody Titer Assay Kit (Mouse) |
MBS8124206-96Tests |
MyBiosource |
96Tests |
EUR 750 |
Human Specific IgG Antibody ELISA Kit |
MBS3802519-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human Specific IgG Antibody ELISA Kit |
MBS3802519-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Specific IgG Antibody ELISA Kit |
MBS3802519-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |